Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,653 | -1,076 | -277 | N/A | -119 |
| Other Working Capital | 388 | 282 | 90 | N/A | 58 |
| Other Operating Activity | 169 | 156 | 17 | 0 | 2 |
| Operating Cash Flow | $-1,096 | $-637 | $-170 | $N/A | $-59 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -1 | N/A | N/A |
| Investing Cash Flow | $-1 | $-1 | $-1 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 29 |
| Common Stock Issued | 861 | 592 | N/A | N/A | 2 |
| Other Financing Activity | 2 | 1 | 11 | 0 | 252 |
| Financing Cash Flow | $863 | $593 | $11 | $N/A | $283 |
| Exchange Rate Effect | -12 | -2 | -1 | N/A | N/A |
| Beginning Cash Position | 573 | 573 | 573 | N/A | 4 |
| End Cash Position | 326 | 525 | 412 | N/A | 228 |
| Net Cash Flow | $-247 | $-48 | $-160 | $N/A | $224 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,096 | -637 | -170 | N/A | -59 |
| Capital Expenditure | -1 | -1 | -1 | N/A | N/A |
| Free Cash Flow | -1,097 | -638 | -171 | 0 | -59 |